![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Clinical Trials
Phesi Powers Data-Driven Clinical Trials Through Addition of New Country Selection Functionality to ClinSite
Phesi, a data-driven provider of clinical development analytics products and solutions, announced a new country selection functionality has been added to ClinSite, its platform...
Clinical Trials
Zydus Cadila announces completion of dosing in Phase I clinical trial of ZyCoV-D
Zydus Cadila, an innovation driven global pharmaceutical company focused on discovering and developing NCEs, Novel Biologicals, Biosimilars and Vaccines, announced that its plasmid DNA...
Clinical Trials
Members of the COVID R&D Alliance and Quantum Leap Healthcare Collaborative Enroll First Patients in I-SPY COVID Trial
Members of the COVID R&D Alliance AbbVie, Inc., Amgen Inc., and Takeda Pharmaceutical Co. Ltd. announced the first patients enrolled in the I-SPY COVID...
Clinical Trials
AbbVie Announces Positive Phase 3 Data for Atogepant in Migraine Prevention
AbbVie announced that the Phase 3 ADVANCE trial evaluating the investigational medicine atogepant, an orally administered calcitonin gene-related peptide (CGRP) receptor antagonist (gepant) met...
Clinical Trials
Pfizer and BioNTech Choose Lead mRNA Vaccine Candidate Against COVID-19 and Pivotal Phase Global Study
Pfizer Inc. and BioNTech SEÂ announced the start of a global (except for China) Phase 2/3 safety and efficacy clinical study to evaluate a single...
Clinical Trials
PCI Pharma Services Announces Global Expansion of Clinical Trial Services
PCI Pharma Services (PCI), a leading pharmaceutical and biopharmaceutical global outsourcing solutions provider, announced a significant milestone in its global clinical footprint with the...
Clinical Trials
Glenmark Announces Top-Line Results From Phase 3 Clinical Trial of Favipiravir in Patients with Mild to Moderate COVID-19
Glenmark Pharmaceuticals Ltd. a global research-led pharmaceutical company announced top-line results from a Phase 3 clinical trial in mild to moderate COVID-19 patients conducted...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read